WHITNEY WYERS: Open Payments
NPI 1972003119 · RUIDOSO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 53 payments from 17 companies in 2025. Trend: 2023 $117 · 2024 $950 · 2025 $1,204
Food & beverage: $1,105Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $314 |
| Actelion Pharmaceuticals US, Inc. | 6 | $206 |
| PFIZER INC. | 5 | $95 |
| Alnylam Pharmaceuticals Inc. | 3 | $90 |
| Merck Sharp & Dohme LLC | 4 | $89 |
| Amgen Inc. | 4 | $77 |
| Medtronic, Inc. | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| ABBVIE INC. | 2 | $36 |
| Novo Nordisk Inc | 2 | $35 |
Products named: FARXIGA, OPSUMIT, AMVUTTRA, VERQUVO, WAINUA, VYNDAQEL, OPSYNVI, REPATHA.
Industry payments across NM — which companies pay providers there.
